Where Will Viking Therapeutics Be in 5 Years?
If you're looking at up-and-coming healthcare stocks with significant potential in the anti-obesity market, one company you've likely come across is Viking Therapeutics (NASDAQ: VKTX). Although the business isn't generating any revenue yet, there's loads of opportunity for the company in the long run.
Below, I'll look at what the future may hold for Viking and whether it could be a good stock to buy and hold for at least the next five years.
The big question surrounding Viking Therapeutics today centers around its promising glucagon-like peptide 1 (GLP-1) drug, VK2735. Within the next five years, investors will likely have learned the fate of the drug and whether it obtains approval from regulators or not.
Source Fool.com
Viking Therapeutics Inc Stock
€48.92
0.660%
Our community is currently high on Viking Therapeutics Inc with 5 Buy predictions and 0 Sell predictions.
With a target price of 100 € there is potential for a 104.42% increase which would mean more than doubling the current price of 48.92 € for Viking Therapeutics Inc.
